Post-earnings recap
Reported
Mon, Mar 19, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss of $0.15 per share for Q4-2017, which did not meet any analyst expectations. The stock reacted negatively, dropping 6.11% in response to the earnings report. The lack of revenue figures and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.15 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.